Dr Gabriell Máté has a strong background in physics, computer science and mathematics. Following a PhD in theoretical biophysics and applied mathematics, he left academia to work as a pricing analyst and data scientist with a focus on the pharmaceutical industry.
He joined Boehringer Ingelheim in 2016 as a lead data scientist where he developed impactful AI solutions to optimize market access and commercial performance of the company globally across a multitude of markets.
He co-founded quantLab (UG), an award-winning AI company that strives to deliver industry-changing AI solutions for pharmaceutical companies.
Gabriell joined Boston Consulting Group in October 2020.